Advertisement

Altered Gene Expression in Tumor Metastasis: The nm23 Gene

  • P. S. Steeg
  • G. Bevilacqua
  • A. M. Rosengard
  • M. E. Sobel
  • V. Cioce
  • L. A. Liotta

Abstract

Tumor metastasis is a complex process involving tumor cell invasion, locomotion, intravasation and extravasation of the circulatory system, angiogenisis, colony formation, and avoidance of host immunological responses. Two premises have guided our investigation into the genetic influences on tumor invasion and metastasis. First, if the metastatic process is regulated, at least in part, by the activation and deactivation of specific genes, then the multiplicity of cell functions in metastasis dictates that many genes are involved. Second, the biochemical nature of molecules regulating and executing each of the tumor cell functions in metastatis is incompletely understood. Because of the tedious purification process, it is likely that many metastasis regulatory and effector compounds and the genes encoding them are presently unknown. Based on these premises, we initiated differential colony hybridization experiments to identify genes associated with the tumor invasion and metastatic process. This technique identifies genes either activated or deactivated between tumor cells of low and high metastatic potential. It can therefore identify metastasis-related genes in advance of conventional biochemical purification and DNA cloning. This paper describes the identification and characterization of one such gene, nm23.

Keywords

Metastatic Process Mouse Mammary Tumor Virus High Metastatic Potential Host Immunological Response RIll Strain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Basolo F, Toniolo A, Fontanini G, Squartini F (1987) Lung colonization and metastasis of murine mammary tumors: relationship to various characteristics of pulmonary tumors. Invastion Metastasis 7:275–283Google Scholar
  2. Fidler IJ (1984) The Ernst W. Bertner Memorial Award Lecture: the evolution of biological heterogeneity in metastatic neoplasms. In: Nicolson GL, Milas L (eds) Cancer invasion and metastasis: biologic and therapeutic aspects. Raven, New York, pp 5–26Google Scholar
  3. Fidler IJ, Gruys E, Cifone MA, Barnes Z, Bucana C (1981) Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. INCI 67:947–953Google Scholar
  4. Kalebic T, Williams JE, Talmadge JE, Kao-shan C-S, Kravitz B, Locklear K, Siegal GP et al. (1988) A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity. Clin Exp Metastasis 6:301–308PubMedCrossRefGoogle Scholar
  5. Muschel RM, Williams JE, Lowy DR, Liotta LA (1985) Harvey ras induction of metastatic potential depends on oncogene activation and the type of recipient cell. Am J Pathol 121:1–8PubMedGoogle Scholar
  6. Pozzatti R, Muschel R, Williams JE, Padmanabhan R, Howard B, Liotta LA, Khoury G (1986) Primary rat embryo fibroblasts transformed by one or two oncogenes show different metastatic potentials. Science 232:223–227PubMedCrossRefGoogle Scholar
  7. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME (1988a) Evidence for a novel gene associated with low tumor metastatic potential. JNCI 80:200–205PubMedGoogle Scholar
  8. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME (1988b) Altered expression of nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res (in press)Google Scholar
  9. Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westin EH, Geilman CA, Talmadge JE, Liotta LA (1985) NIH3T3 cells transfected with human tumor DDN A containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5:259–262PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • P. S. Steeg
    • 1
  • G. Bevilacqua
    • 1
  • A. M. Rosengard
    • 1
  • M. E. Sobel
    • 1
  • V. Cioce
    • 1
  • L. A. Liotta
    • 1
  1. 1.Laboratory of PathologyNational Cancer Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations